Photo from Tom Powles/X
May 26, 2024, 11:35
Bladder cancer highlights for ASCO24 by Tom Powles
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“Bladder cancer highlights for ASCO24. Practice informing data. .
PK and QOL data for EV/EVP are helpful. Highlighting responders for gem/cis/nivo in M1 disease informs us about the winners.
ctDNA/ctDNA clearance in M1 disease for chemo vs pembro looks new. Neoadjuvant SG plus IO is important.”
Source: Tom Powles/X